BIO INVENTION AS
Clinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Yleiskatsaus
- Tuntematon
- Työntekijät
- 22t NOK
- Liikevaihto
- 2004
- Perustettu
Avainpäättäjät
Björn Frendéus
Science Advisory Board Member
Mona Welschof
Clinical Operations/Development Lead
Linda Mårtensson
Employee
Sylvie Ryckebusch
Business Development
Kuvaus
BioInvent is a clinical-stage biotechnology company focused on discovering and developing innovative antibody therapeutics for cancer treatment. The core of their work lies in leveraging deep expertise in immunology, cancer biology, and antibody biology to generate novel immuno-oncology drug candida...